Healio Rheumatology Current Issue
The following articles appeared in the print edition of Healio Rheumatology.
Table of Contents
- Workforce shortage: Selling a specialty that should sell itself Rob Volansky
-
- Filgotinib drops out of US arthritis race: Gilead ends bid for FDA approval Jason Laday
- The rheumatologist and COVID-19 at 1 year: The good, the bad and the ugly Leonard H. Calabrese, DO
- Court ruling in orphan drug lawsuit reframes outlook on market exclusivity Rob Volansky
- ACR recommends 'stepwise approach' to immunomodulatory therapy in MIS-C linked to COVID-19 Jason Laday
- Baseline prednisone use tied to poor outcomes in tapering hydroxychloroquine for lupus Jason Laday
- COVID-19 prompts prenatal care changes in 67% of pregnant patients with rheumatic disease Jason Laday
- DASH diet reduces serum urate, especially in those with hyperuricemia Jason Laday
- Drug access issues, COVID-related distress linked to rheumatic disease activity, flares Jason Laday
-
- Duloxetine plus usual care cost effective in moderate-pain knee OA Jason Laday
- EULAR: All rheumatic, musculoskeletal disease providers should stress therapy adherence Jason Laday
- Hydroxychloroquine for RA does not increase risk for suicide, depression Jason Laday
- Larger sample sizes, longer duration needed for osteoarthritis drug trials Jason Laday
- Patients with checkpoint-induced myositis, overlap syndrome face worse outcomes Jason Laday
- Patients with inflammatory rheumatic disease more likely to be hospitalized with COVID-19 Jason Laday
- Prednisone for 1 month or longer a key predictor of osteonecrosis in lupus Jason Laday
- Rheumatic patients often avoided office visits in early months of COVID-19 pandemic Jason Laday
-
- Risks for severe COVID-19 outcomes in patients with rheumatic disease 'remain substantial' Jason Laday
- Steroids, not DMARDs, increase risk for COVID-19 infection in inflammatory arthritis Jason Laday
- TNF inhibitors do not increase solid cancer risk in PsA Jason Laday
- Use of subclinical synovitis to classify RA yields high false-positive rate Jason Laday
- Navigating COVID-19 vaccine hesitancy: What are you telling your patients? Rob Volansky